Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Galmed Pharmaceuticals Ltd GLMD

Healthcare Biotechnology
Galmed Pharmaceuticals is a Israeli-based clinical-stage biopharmaceutical company.The activiti of the Company is focused on the development therapy for treating liver diseases. Arachmol, the main product of Galmed Pharmaceuticals, is a liver-targeted stearoyl-coenzyme A desaturase1 used in oral therapy for the treatment of NASH (Non-alcoholic Steatohepatitis).


NDAQ:GLMD - Post by User

Galmed Pharmaceuticals Ltd
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(70)
•••
Post by Iseneschalon Sep 17, 2024 11:51am
35 Views
Post# 36227304

GLMD.....calling all Chasers ; )

GLMD.....calling all Chasers ; )Us Short sellers need a home

P.O set up ......leading all you buyers to the "Slaughter House"

sec.gov/Archives/edgar/data/1595353/000149315224035476/form424b3.htm
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities